These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8386005)

  • 21. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influences of an analog of the neuropeptide ACTH 4--9 on mentally retarded adults.
    Walker BB; Sandman CA
    Am J Ment Defic; 1979 Jan; 83(4):346-52. PubMed ID: 217271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choline chloride fails to improve cognition of Alzheimer's disease.
    Thal LJ; Rosen W; Sharpless NS; Crystal H
    Neurobiol Aging; 1981; 2(3):205-8. PubMed ID: 7312098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal ACTH fragments increase the CSF beta-EP content in Alzheimer type dementia.
    Nappi G; Facchinetti F; Martignoni E; Petraglia F; Sinforiani E; Bono G; Genazzani AR
    Acta Neurol Scand; 1988 Aug; 78(2):146-51. PubMed ID: 2845700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Arch Gen Psychiatry; 1986 Aug; 43(8):727-32. PubMed ID: 3729666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
    Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T
    Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple-dose arecoline infusions in Alzheimer's disease.
    Tariot PN; Cohen RM; Welkowitz JA; Sunderland T; Newhouse PA; Murphy DL; Weingartner H
    Arch Gen Psychiatry; 1988 Oct; 45(10):901-5. PubMed ID: 3048224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior.
    Buitelaar JK; van Engeland H; de Kogel KH; de Vries H; van Hooff JA; van Ree JM
    Biol Psychiatry; 1992 Jun; 31(11):1119-29. PubMed ID: 1326339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single injection of a biodegradable microsphere formulation of the ACTH-(4-9) analogue ORG 2766 accelerates functional recovery after brain damage.
    Wolterink G; Bouwman TR; Eenink MJ; De Nijs H; van Ree JM
    J Pharm Pharmacol; 1990 Jul; 42(7):508-10. PubMed ID: 1980295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural modifications of the ACTH-(4-9) analog ORG 2766 yields peptides with high biological activity.
    Wolterink G; van Ree JM; van Nispen JW; de Wied D
    Life Sci; 1991; 48(2):155-61. PubMed ID: 1847225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
    Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B
    Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive effects of ACTH 4-10 in the elderly.
    Ferris SH; Sathananthan G; Gershon S; Clark C; Moshinsky J
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):73-8. PubMed ID: 189334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.
    van der Hoop RG; Vecht CJ; van der Burg ME; Elderson A; Boogerd W; Heimans JJ; Vries EP; van Houwelingen JC; Jennekens FG; Gispen WH
    N Engl J Med; 1990 Jan; 322(2):89-94. PubMed ID: 2152972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choline bitartrate treatment of Alzheimer-type dementias.
    Fovall P; Dysken MW; Lazarus LW; Davis JM; Kahn RL; Jope R; Finkel S; Rattan P
    Commun Psychopharmacol; 1980; 4(2):141-5. PubMed ID: 7428335
    [No Abstract]   [Full Text] [Related]  

  • 37. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-deprenyl in Alzheimer's disease: cognitive and behavioral effects.
    Freedman M; Rewilak D; Xerri T; Cohen S; Gordon AS; Shandling M; Logan AG
    Neurology; 1998 Mar; 50(3):660-8. PubMed ID: 9521253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.
    Xiao S; Wang T; Ma X; Qin Y; Li X; Zhao Z; Liu X; Wang X; Xie H; Jiang Q; Sun L; Luo B; Shang L; Chen W; Bai Y; Tang M; He M; Wu L; Ma Q; Hou D; He J
    Age Ageing; 2017 Sep; 46(5):767-773. PubMed ID: 28419192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-related facilitation and inhibition of passive avoidance behavior by the ACTH 4-9 analog (ORG 2766).
    Fekete M; De Wied D
    Pharmacol Biochem Behav; 1982 Aug; 17(2):177-82. PubMed ID: 6291064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.